Literature DB >> 12744484

Hemorrhagic shock induces an S 100 B increase associated with shock severity.

Linda E Pelinka1, Soheyl Bahrami, Laszlo Szalay, Fraz Umar, Heinz Redl.   

Abstract

S 100 B is a glial marker of cerebral Injury. In a previous clinical study, we found an S 100 B increase within the first 24 h in patients with multiple trauma and hemorrhagic shock but without cerebral trauma. The aim of our current experimental study was to determine whether this posttraumatic S 100 B increase is caused by extracerebral soft tissue injury or by hemorrhagic shock and whether it is associated with the severity of hemorrhagic shock. Hemorrhagic shock was achieved by bleeding anesthetized rats to a mean arterial pressure (MAP) of 30-35 mmHg through a femoral catheter and maintaining this MAP until incipient decompensation. At incipient decompensation, MAP was either increased immediately to 40-45 mmHg (moderate shock) or was maintained until 40% of shed blood had been returned (severe shock), and then increased to 40-45 mmHg. Resuscitation was provided after 40-45 mmHg MAP had been maintained for 40 min. Soft tissue injury was achieved by midline laparotomy performed at the onset of hemorrhagic shock or without shock and was maintained for 30 min. Hemorrhagic shock caused an early S 100 B increase at the onset of decompensation. S 100 B remained increased for 24 h and was significantly higher after severe than after moderate shock. In contrast, soft tissue injury without hemorrhagic shock caused no S 100 B increase. The data presented demonstrate for the first time that the S 100 B increase is induced by hemorrhagic shock and is associated with the severity of shock.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12744484     DOI: 10.1097/01.shk.0000055345.58165.52

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  9 in total

1.  Redistribution of labile plasma zinc during mild surgical stress in the rat.

Authors:  Edward Kelly; Jeffrey Mathew; Jonathan E Kohler; Amy L Blass; David I Soybel
Journal:  Transl Res       Date:  2011-01-12       Impact factor: 7.012

2.  Correlation of cerebral Near-infrared spectroscopy (cNIRS) and neurological markers in critically ill children.

Authors:  Anjali Subbaswamy; Angela A Hsu; Steven Weinstein; Michael J Bell
Journal:  Neurocrit Care       Date:  2009       Impact factor: 3.210

Review 3.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

4.  Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update.

Authors:  Johan Undén; Tor Ingebrigtsen; Bertil Romner
Journal:  BMC Med       Date:  2013-02-25       Impact factor: 8.775

5.  Application of NICE or SNC guidelines may reduce the need for computerized tomographies in patients with mild traumatic brain injury: a retrospective chart review and theoretical application of five guidelines.

Authors:  Sebastian Svensson; Tomas Vedin; Linus Clausen; Per-Anders Larsson; Marcus Edelhamre
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2019-11-04       Impact factor: 2.953

6.  Integration of proteomics, bioinformatics, and systems biology in traumatic brain injury biomarker discovery.

Authors:  J D Guingab-Cagmat; E B Cagmat; R L Hayes; J Anagli
Journal:  Front Neurol       Date:  2013-05-31       Impact factor: 4.003

7.  A New Technique for Collection of Cerebrospinal Fluid in Rat Pups.

Authors:  Javier Rodríguez-Fanjul; Cristina Durán Fernández-Feijóo; Marta Camprubí Camprubí
Journal:  J Exp Neurosci       Date:  2015-05-24

Review 8.  S100B protein in serum is elevated after global cerebral ischemic injury.

Authors:  Bao-di Sun; Hong-Mei Liu; Shi-Nan Nie
Journal:  World J Emerg Med       Date:  2013

9.  Ringer's lactate solution enhances the inflammatory response during fluid resuscitation of experimentally induced haemorrhagic shock in rats.

Authors:  Krzysztof Kusza; Mariusz Mielniczuk; Lukasz Krokowicz; Jacek B Cywiński; Maria Siemionow
Journal:  Arch Med Sci       Date:  2017-09-05       Impact factor: 3.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.